Kim J
1] Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, South Korea [2] Research Institute of Medical Nutrition, Kyung Hee University, Seoul, South Korea.
Eur J Clin Nutr. 2015 Apr;69(4):425-30. doi: 10.1038/ejcn.2014.192. Epub 2014 Sep 24.
BACKGROUND/OBJECTIVES: This study explored the association between serum 25-hydroxyvitamin D (25(OH)D) or parathyroid hormone (PTH) concentrations and the risk of metabolic syndrome (MetS) in middle-aged and older Korean adults using the most recent, nationally representative survey data.
SUBJECTS/METHODS: The study sample consisted of 2624 Korean adults (⩾ 50 years old) who participated in the fifth Korean National Health and Nutrition Examination Surveys. Serum 25(OH)D was measured by radioimmunoassay and serum PTH was measured using chemiluminescence assay. MetS was defined according to the joint interim statement of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute.
Serum 25(OH)D concentrations were significantly lower in subjects with MetS than in subjects without MetS, and the prevalence of MetS significantly decreased according to quartiles of serum 25(OH)D concentration. Serum 25(OH)D concentrations were negatively associated with the risk of elevated blood pressure (P for trend = 0.039), hypertriglyceridemia (P for trend = 0.0474) and reduced high-density lipoprotein cholesterol (P for trend= 0.0139), whereas serum PTH concentrations were positively associated with the risk of elevated blood pressure (P for trend = 0.0002) after adjusting for age, gender, residential district, education level, income, smoking status, body mass index, alcohol intake and physical activity. Furthermore, serum 25(OH)D concentrations were inversely associated with the risk of MetS after adjusting for confounding factors (P for trend = 0.0163). However, serum PTH concentrations were not associated with the risk of MetS.
Serum 25(OH)D concentration may be an independent risk factor of MetS among middle-aged and older Korean adults.
背景/目的:本研究利用最新的全国代表性调查数据,探讨韩国中老年成年人血清25-羟维生素D(25(OH)D)或甲状旁腺激素(PTH)浓度与代谢综合征(MetS)风险之间的关联。
对象/方法:研究样本包括2624名参加第五次韩国国民健康与营养检查调查的韩国成年人(年龄≥50岁)。采用放射免疫分析法测定血清25(OH)D,采用化学发光分析法测定血清PTH。根据国际糖尿病联盟和美国心脏协会/国家心肺血液研究所的联合临时声明定义MetS。
患有MetS的受试者血清25(OH)D浓度显著低于未患MetS的受试者,且MetS的患病率随血清25(OH)D浓度四分位数显著降低。血清25(OH)D浓度与血压升高风险呈负相关(趋势P=0.039)、与高甘油三酯血症呈负相关(趋势P=0.0474)、与高密度脂蛋白胆固醇降低呈负相关(趋势P=0.0139),而在调整年龄、性别、居住地区、教育水平、收入、吸烟状况、体重指数、酒精摄入量和身体活动后,血清PTH浓度与血压升高风险呈正相关(趋势P=0.0002)。此外,在调整混杂因素后,血清25(OH)D浓度与MetS风险呈负相关(趋势P=0.0163)。然而,血清PTH浓度与MetS风险无关。
血清25(OH)D浓度可能是韩国中老年成年人MetS的独立危险因素。